Pro-inflammatory cytokines such as IL-2, IL-12, and IL-15 can improve antigen priming, increase the number of effector immune cells in the tumor immune microenvironment and enhance cytolytic activity (Berraondo et al., 2019). Here, IL2 is linked to neoplasm.